Loading organizations...
Fujifilm is a Tokyo, Japan-based holding company that develops and manufactures a wide range of products across imaging, healthcare, materials science, and business solutions. The publicly traded corporation operates globally with a massive worldwide workforce of 72,593 employees and reported a market capitalization of approximately $27 billion in early 2025. During the 2025 fiscal year, the enterprise generated ¥3.2 trillion, or roughly $21 billion, in total revenue through its diversified portfolio of medical diagnostics, pharmaceuticals, digital cameras, and commercial printers. Led by Chief Executive Officer Teiichi Goto and Chairman Kenji Sukeno, the organization has expanded its operations through key subsidiaries like Fuji Xerox and strategic acquisitions, including the ¥22 billion purchase of Toyama Chemical. The multinational enterprise was originally established in 1934 by its founding parent organization, the Dainippon Celluloid Company, also known as Daicel.
Key people at Fujifilm.
Fujifilm has 1 tracked investment across 1 company. The latest tracked deal is $210.0M Series A in Tome Biosciences in December 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2023 | Tome Biosciences | $210.0M Series A | — | Andreessen Horowitz, ARCH Venture Partners, Bessemer Venture Partners, Daniel Lynch, GV, Polaris Partners, Timothy A. Springer, Alexandria Venture Investments, Jorge Conde, BIO + Health, Bruker, Longwood Fund, Alan Crane |
Key people at Fujifilm.